282 related articles for article (PubMed ID: 34192335)
41. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
42. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
Carlin AF; Uchiyama S; Chang YC; Lewis AL; Nizet V; Varki A
Blood; 2009 Apr; 113(14):3333-6. PubMed ID: 19196661
[TBL] [Abstract][Full Text] [Related]
43. Dual actions of group B
Uchiyama S; Sun J; Fukahori K; Ando N; Wu M; Schwarz F; Siddiqui SS; Varki A; Marth JD; Nizet V
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7465-7470. PubMed ID: 30910970
[TBL] [Abstract][Full Text] [Related]
44. Tools to study and target the Siglec-sialic acid axis in cancer.
Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
[TBL] [Abstract][Full Text] [Related]
45. The interplay between Siglecs and sialylated pathogens.
Chang YC; Nizet V
Glycobiology; 2014 Sep; 24(9):818-25. PubMed ID: 24996821
[TBL] [Abstract][Full Text] [Related]
46. Current Status on Therapeutic Molecules Targeting Siglec Receptors.
Lenza MP; Atxabal U; Oyenarte I; Jiménez-Barbero J; Ereño-Orbea J
Cells; 2020 Dec; 9(12):. PubMed ID: 33333862
[TBL] [Abstract][Full Text] [Related]
47. The female reproductive tract contains multiple innate sialic acid-binding immunoglobulin-like lectins (Siglecs) that facilitate sperm survival.
Tecle E; Reynoso HS; Wang R; Gagneux P
J Biol Chem; 2019 Aug; 294(31):11910-11919. PubMed ID: 31201275
[TBL] [Abstract][Full Text] [Related]
48. Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen.
Schwarz F; Landig CS; Siddiqui S; Secundino I; Olson J; Varki N; Nizet V; Varki A
EMBO J; 2017 Mar; 36(6):751-760. PubMed ID: 28100677
[TBL] [Abstract][Full Text] [Related]
49. Unraveling Molecular Recognition of Glycan Ligands by Siglec-9 via NMR Spectroscopy and Molecular Dynamics Modeling.
Atxabal U; Nycholat C; Pröpster JM; Fernández A; Oyenarte I; Lenza MP; Franconetti A; Soares CO; Coelho H; Marcelo F; Schubert M; Paulson JC; Jiménez-Barbero J; Ereño-Orbea J
ACS Chem Biol; 2024 Feb; 19(2):483-496. PubMed ID: 38321945
[TBL] [Abstract][Full Text] [Related]
50. Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses.
Daly J; Sarkar S; Natoni A; Stark JC; Riley NM; Bertozzi CR; Carlsten M; O'Dwyer ME
Blood Adv; 2022 Jun; 6(11):3352-3366. PubMed ID: 35294519
[TBL] [Abstract][Full Text] [Related]
51. Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
Angata T
Front Immunol; 2018; 9():2885. PubMed ID: 30564250
[TBL] [Abstract][Full Text] [Related]
52. Deacetylated Sialic Acid Sensitizes Lung and Colon Cancers to Novel Cucurbitacin-Inspired Estrone Epidermal Growth Factor Receptor (EGFR) Inhibitor Analogs.
Anim MT; Tuffour I; Willis R; Schell M; Ostlund T; Mahnashi MH; Halaweish F; Willand-Charnley R
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687086
[TBL] [Abstract][Full Text] [Related]
53. Carbohydrate Sulfation As a Mechanism for Fine-Tuning Siglec Ligands.
Jung J; Enterina JR; Bui DT; Mozaneh F; Lin PH; Nitin ; Kuo CW; Rodrigues E; Bhattacherjee A; Raeisimakiani P; Daskhan GC; St Laurent CD; Khoo KH; Mahal LK; Zandberg WF; Huang X; Klassen JS; Macauley MS
ACS Chem Biol; 2021 Nov; 16(11):2673-2689. PubMed ID: 34661385
[TBL] [Abstract][Full Text] [Related]
54. A Chemical Biology Solution to Problems with Studying Biologically Important but Unstable 9-O-Acetyl Sialic Acids.
Khedri Z; Xiao A; Yu H; Landig CS; Li W; Diaz S; Wasik BR; Parrish CR; Wang LP; Varki A; Chen X
ACS Chem Biol; 2017 Jan; 12(1):214-224. PubMed ID: 27936566
[TBL] [Abstract][Full Text] [Related]
55. Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2.
Wieboldt R; Sandholzer M; Carlini E; Lin CW; Börsch A; Zingg A; Lardinois D; Herzig P; Don L; Zippelius A; Läubli H; Mantuano NR
Cell Mol Immunol; 2024 May; 21(5):495-509. PubMed ID: 38448555
[TBL] [Abstract][Full Text] [Related]
56. Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation.
Sabit I; Hashimoto N; Matsumoto Y; Yamaji T; Furukawa K; Furukawa K
J Biol Chem; 2013 Dec; 288(49):35417-27. PubMed ID: 24145038
[TBL] [Abstract][Full Text] [Related]
57. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
[TBL] [Abstract][Full Text] [Related]
58. A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor.
Sonnenburg JL; Altheide TK; Varki A
Glycobiology; 2004 Apr; 14(4):339-46. PubMed ID: 14693915
[TBL] [Abstract][Full Text] [Related]
59. Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity.
Huang J; Li M; Mei B; Li J; Zhu Y; Guo Q; Huang J; Zhang G
J Transl Med; 2022 Oct; 20(1):496. PubMed ID: 36316782
[TBL] [Abstract][Full Text] [Related]
60. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands.
Rodrigues E; Jung J; Park H; Loo C; Soukhtehzari S; Kitova EN; Mozaneh F; Daskhan G; Schmidt EN; Aghanya V; Sarkar S; Streith L; St Laurent CD; Nguyen L; Julien JP; West LJ; Williams KC; Klassen JS; Macauley MS
Nat Commun; 2020 Oct; 11(1):5091. PubMed ID: 33037195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
